Ethical dimensions of genetics in pediatric neurology: A look into the future

Seminars in Pediatric Neurology

Volumn 9, Issue 1, 2002, Pages 53-61

  Avard, Denise M ^a   Knoppers, Bartha M ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DATA BASE; FAMILY; GENE THERAPY; GENETIC ANALYSIS; GENETIC SCREENING; HEALTH CARE POLICY; HEALTH EDUCATION; HUMAN; INFORMED CONSENT; LEGAL ASPECT; MEDICAL ETHICS; MEDICAL RESEARCH; NEUROLOGIC DISEASE; PEDIATRICS; PRACTICE GUIDELINE; REVIEW; RISK BENEFIT ANALYSIS; SOCIAL ASPECT;

EID: 0036118434     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1053/spen.2002.30342     Document Type: Article

References (57)

1. Contribution of birth defects and genetic diseases to pediatric hospitalizations: A population-based study
2. Statement on gene therapy research
3. Selected legal and ethical issues relevant to pediatric genetics
4. Genetic testing, legal capacity and adolescents
5. Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: Convention on human rights and biomedicine
6. Guidelines for the ethical conduct of medical research involving children
7. Proposed international guidelines on ethical issues in medical genetics and genetic service
8. Review of legal instruments and codes on medical experimentation with children
9. Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents
10. Human genetic research, DNA banking and consent: A question of "form"?
11. Gene therapy: Trials and tribulations
12. Cell therapy in Parkinson's disease - Stop or go?
13. Law no. 56 of 5 August 1994 on the medical use of biotechnology
14. Regulating work with genetically modified organisms, the release and marketing of genetically modified organisms, and the use of genetic testing and gene therapy in humans (the Gene Technology Law), and amending the product liability law
15. Vulnerable children
16. Resolution on the ethical and legal problems of genetic engineering
17. Genetic testing for children and adolescents. Who decides?
18. Developmental tasks of childhood and adolescence: Implications for genetic testing
19. Childhood, genetics, ethics and the social context
20. The genetic testing of children
21. Ethical and legal issues in genetic epidemiology
22. Psychosocial effects of screening for somatic risk: The Swedish alpha 1 antitrypsin experience
23. Predictive genetic testing in children: Paternalism or empiricism?
24. The diagnostic evaluation and multidisciplinary management of neurofibromatosis I and neurofibromatosis 2
25. Partnerships with children
26. The competency of children and adolescents to make informed treatment decisions
27. Talking to children - And talking with them
28. What do adolescents need for a healthy development? Implications for youth policies
29. Code of ethical principles for genetics professionals: An explication
30. Review by a local medical research ethics committee of the conduct of approved research projects, by examination of patients' case notes, consent forms, and research records and by interview
31. C.A.R.E.: An approach for teaching ethics in medicine
32. Knowledge of ethical standards in genetic testing among medical students, residents, and practicing physicians
33. Deciding for imperiled newborns: Medical authority or parental autonomy?
34. Consumer perspectives on genetic testing: Lessons learned
35. Impact of genetic information and genetic counseling on public health
36. Thoughts concerning societal, legal and ethical ramifications of the human genome project
37. Information and education committee report from the ASHG: Medical school core curriculum in genetics
38. Genetics and society project
39. Public participation in medical policy-making and the status of consumer autonomy: The example of newborn-screening programs in the United States